Insulet Corporation GOV.F Stock
Insulet Corporation Price Chart
Insulet Corporation GOV.F Financial and Trading Overview
| Insulet Corporation stock price | 164.2 EUR |
| Previous Close | 260.9 EUR |
| Open | 261.5 EUR |
| Bid | 261.7 EUR x 12100 |
| Ask | 263 EUR x 11600 |
| Day's Range | 261.5 - 261.5 EUR |
| 52 Week Range | 188.72 - 313.45 EUR |
| Volume | 80 EUR |
| Avg. Volume | 5 EUR |
| Market Cap | 18.31B EUR |
| Beta (5Y Monthly) | 0.791901 |
| PE Ratio (TTM) | Infinity |
| EPS (TTM) | 2.74 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 290.41 EUR |
GOV.F Valuation Measures
| Enterprise Value | 19.01B EUR |
| Trailing P/E | Infinity |
| Forward P/E | 168.70969 |
| PEG Ratio (5 yr expected) | 5.01 |
| Price/Sales (ttm) | 13.386697 |
| Price/Book (mrq) | 36.24896 |
| Enterprise Value/Revenue | 13.895 |
| Enterprise Value/EBITDA | 161.498 |
Trading Information
Insulet Corporation Stock Price History
| Beta (5Y Monthly) | 0.791901 |
| 52-Week Change | 37.26% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 313.45 EUR |
| 52 Week Low | 188.72 EUR |
| 50-Day Moving Average | 282.3 EUR |
| 200-Day Moving Average | 272.12 EUR |
GOV.F Share Statistics
| Avg. Volume (3 month) | 5 EUR |
| Avg. Daily Volume (10-Days) | 8 EUR |
| Shares Outstanding | 69.7M |
| Float | 69.37M |
| Short Ratio | N/A |
| % Held by Insiders | 0.40% |
| % Held by Institutions | 104.38% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0.044% |
| Operating Margin (ttm) | 3.84% |
| Gross Margin | 61.14% |
| EBITDA Margin | 8.60% |
Management Effectiveness
| Return on Assets (ttm) | 1.50% |
| Return on Equity (ttm) | 0.12% |
Income Statement
| Revenue (ttm) | 1.37B EUR |
| Revenue Per Share (ttm) | 19.7 EUR |
| Quarterly Revenue Growth (yoy) | 21.19% |
| Gross Profit (ttm) | 805.6M EUR |
| EBITDA | 117.7M EUR |
| Net Income Avi to Common (ttm) | 600K EUR |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | -14.39% |
Balance Sheet
| Total Cash (mrq) | 620.7M EUR |
| Total Cash Per Share (mrq) | 8.91 EUR |
| Total Debt (mrq) | 1.4B EUR |
| Total Debt/Equity (mrq) | 277.76 EUR |
| Current Ratio (mrq) | 3.47 |
| Book Value Per Share (mrq) | 7.214 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 133.2M EUR |
| Levered Free Cash Flow (ttm) | -27387500 EUR |
Profile of Insulet Corporation
| Country | Germany |
| State | MA |
| City | Acton |
| Address | 100 Nagog Park |
| ZIP | 01720 |
| Phone | 978 600 7000 |
| Website | https://www.insulet.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 2600 |
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Q&A For Insulet Corporation Stock
What is a current GOV.F stock price?
Insulet Corporation GOV.F stock price today per share is 164.2 EUR.
How to purchase Insulet Corporation stock?
You can buy GOV.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Insulet Corporation?
The stock symbol or ticker of Insulet Corporation is GOV.F.
Which industry does the Insulet Corporation company belong to?
The Insulet Corporation industry is Medical Devices.
How many shares does Insulet Corporation have in circulation?
The max supply of Insulet Corporation shares is 70.02M.
What is Insulet Corporation Price to Earnings Ratio (PE Ratio)?
Insulet Corporation PE Ratio is 59.92700600 now.
What was Insulet Corporation earnings per share over the trailing 12 months (TTM)?
Insulet Corporation EPS is 2.74 EUR over the trailing 12 months.
Which sector does the Insulet Corporation company belong to?
The Insulet Corporation sector is Healthcare.